Semaglutide Injectable Product trials for Obesity

All Semaglutide Injectable Product trials · All Obesity trials

Phase breakdown

Recruiting trials studying Semaglutide Injectable Product for Obesity

• Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity
  NCT07136714 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Effect of Weight Loss on Physical and Cardiac Performance in People With Obesity and Heart Failure
  NCT06423599 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV
  NCT04174755 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Semaglutide Injectable Product for Obesity?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.